Risk factors for autoimmune liver disease recurrence after liver transplantation

Figure 1 Patient inclusion and exclusion, cirrhosis etiology, and disease recurrence rate. AIH: Autoimmune hepatitis; AILD: Autoimmune liver disease; MASLD: Metabolic dysfunction-associated steatotic liver disease; PBC: Primary biliary cholangitis; PSC: Primary sclerosing cholangitis.

Figure 2 Cumulative incidence of autoimmune liver disease recurrence following liver transplantation. AILD: Autoimmune liver disease.

Figure 3 Area under the receiver operating characteristic curve curves of exploratory models predicting autoimmune liver disease recurrence. Model 1 assessed the duration and severity of autoimmune liver disease. Models 2 and 3 analyzed surrogates of liver disease activity and systemic inflammation based on laboratory values at baseline (model 2) and three months after transplantation (model 3). Model 4 evaluated potential factors associated with reduced treatment adherence and the need for dose adjustments. ROC: Receiver operating characteristic.